Erythropoietin and Early Iron Supplement and Retinopathy of Prematurity

The Possible Influence of Erythropoietin and Early Iron Supplements on the Prevalence and Severity of Retinopathy of Prematurity and Other Short Term Outcome of Prematurity

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00339001

Enrollment

400

Registered

2006-06-20

Start date

2006-04-30

Completion date

2006-12-31

Last updated

2006-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinopathy of Prematurity

Keywords

Erythropoietin, Iron, Retinopathy of prematurity

Brief summary

To evaluate the possibility that erythropoietin with early iron supplementation may induce retinopathy of prematurity or worsen this disease. In addition risk factors for the development of ROP will be checked.

Interventions

DRUGerythropoietin and early iron supplements

Study design

Observational model

DEFINED_POPULATION

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

2 Weeks to 3 Months

Healthy volunteers

Inclusion criteria

* all premature infants with birth weight of 1250 grams or less

Exclusion criteria

* none

Countries

Israel

Contacts

Primary ContactJacob Kuint, MD

kuint-j@sheba.health.gov.il972-3-5303030

Backup ContactIrit Eisen, MD

972-3-5303030

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026